Contested Medicine
Cancer Research and the Military
Contested Medicine
Cancer Research and the Military
In the 1960s University of Cincinnati radiologist Eugene Saenger infamously conducted human experiments on patients with advanced cancer to examine how total body radiation could treat the disease. But, under contract with the Department of Defense, Saenger also used those same patients as proxies for soldiers to answer questions about combat effectiveness on a nuclear battlefield.
Using the Saenger case as a means to reconsider cold war medical trials, Contested Medicine examines the inherent tensions at the heart of clinical studies of the time. Emphasizing the deeply intertwined and mutually supportive relationship between cancer therapy with radiation and military medicine, Gerald Kutcher explores post–World War II cancer trials, the efforts of the government to manage clinical ethics, and the important role of military investigations in the development of an effective treatment for childhood leukemia. Whereas most histories of human experimentation judge research such as Saenger’s against idealized practices, Contested Medicine eschews such an approach and considers why Saenger’s peers and later critics had so much difficulty reaching an unambiguous ethical assessment. Kutcher’s engaging investigation offers an approach to clinical ethics and research imperatives that lays bare many of the conflicts and tensions of the postwar period.
264 pages | 6 x 9 | © 2009
Biological Sciences: Biochemistry
History: American History, Military History
Reviews
Table of Contents
Introduction
Part I. Research Imperatives and Clinical Ethics
1 Cancer Clinical Trials
2 The Production of Trustworthy Knowledge
3 Military Medicine and Cancer Therapy
Part II. A Case of Contested Knowledge
4 Cancer Patients as Proxy Soldiers
5 A Cancer Patient’s Story
6 Peer Review
7 Public Disclosure
Part III. Attempts at Closure
8 Ethical Judgment
Epilogue
Bibliography
Index
Be the first to know
Get the latest updates on new releases, special offers, and media highlights when you subscribe to our email lists!